冠状动脉旁路移植术后的长期生存:三支病变与正常射血分数患者的基准
该多中心回顾性研究分析了2008至2020年间11个中心4061例因稳定三支病变、正常射血分数行择期首次孤立CABG的患者,对比年龄性别匹配的美国人群,显示CABG患者生存改善且相对生存随时间增加。死亡相关因素包括年龄≥65岁、男性、糖尿病、透析、中重度慢性肺病和外周动脉疾病。
要点
- 择期CABG治疗稳定三支病变正常射血分数患者,生存优于年龄性别匹配的美国人群。
- 年龄≥65岁、男性、糖尿病、透析、中重度慢性肺病、外周动脉疾病与死亡风险增加相关。
- 该基准有助于后续研究比较手术与药物治疗的相对作用。
核心结论
- 稳定三支病变且射血分数正常的患者行择期CABG后,生存优于年龄和性别匹配的美国人群,且相对生存随时间显著增加。
研究设计与样本
- 多中心回顾性队列研究,纳入2008至2020年间11个中心连续4061例因稳定三支病变、正常射血分数行择期首次孤立CABG的患者。
- 生存数据来自美国疾病控制与预防中心国家死亡索引,并与年龄性别匹配的美国人群比较;采用以医院为随机效应的混合效应模型分析全因死亡相关因素。
主要发现
- 4061例患者中893例(22%)为女性,中位年龄68岁(四分位距61-74岁)。
- 与年龄和性别匹配的美国人群相比,择期CABG患者生存改善,相对生存随时间显著增加。
临床怎么用
- 对于稳定三支病变且射血分数正常的患者,择期CABG可提供优于一般人群的长期生存,可作为治疗决策的参考基准。
- 合并年龄≥65岁、糖尿病、透析、中重度慢性肺病或外周动脉疾病者死亡风险较高,应加强围术期风险评估与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Management guidelines for stable 3-vessel coronary artery disease have become a subject of debate. We aim to provide a benchmark for the survival of patients with normal ejection fraction, stable 3-vessel disease, and elective coronary artery bypass graft (CABG) surgery. METHODS: Data from consecutive patients with normal ejection fraction undergoing elective primary isolated CABG for 3-vessel disease in a diverse 11-center surgical network between 2008 and 2020 were analyzed. Survival data were obtained from the Centers for Disease Control and Prevention National Death Index and compared with an age- and sex-matched United States population. Mixed-effects modeling with "hospital" as a random effect was used to evaluate factors associated with all-cause mortality. RESULTS: Of 4061 patients included in this analysis, 893 (22%) were women, and the median age was 68 years (interquartile range, 61-74 years). Patients with elective CABG surgery for 3-vessel disease and normal ejection fraction demonstrated improved survival compared with an age- and sex-matched United States population, with significantly increasing relative survival over time. Factors associated with mortality included age ≥65 years (hazard ratio [HR], 1.71; P < .001), male sex (HR, 1.32; P = .028), diabetes (HR, 1.4; P = .002), dialysis (HR, 2.41; P = .03), moderate or severe chronic lung disease (HR, 1.68; P < .001), and peripheral arterial disease (HR, 2.05; P < .001). CONCLUSIONS: Patients with stable 3-vessel disease and normal ejection fraction who underwent elective CABG demonstrated improved survival compared with an age- and sex-matched United States population. With this benchmark, further research can better elucidate the relative role of surgery and medical therapy in this patient population.
引用
- Vyas C, Wang P, Sun J, et al. Long-Term Survival After Coronary Artery Bypass Graft Surgery. Ann Thorac Surg. 2025. PMID: 39828077. doi:10.1016/j.athoracsur.2024.12.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。